-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BQWa2Vg/fkxqbXzxdNUgkC5yM2kt/0tc/bauCjUo/yNcXiZZayGVwJ29WIOiSs+O 24zedmwM/ovEvkd0KSKVqg== 0001017951-00-000098.txt : 20000418 0001017951-00-000098.hdr.sgml : 20000418 ACCESSION NUMBER: 0001017951-00-000098 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000207 ITEM INFORMATION: FILED AS OF DATE: 20000417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERIMMUNE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000818808 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 841044910 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-22865 FILM NUMBER: 602871 BUSINESS ADDRESS: STREET 1: 21550 OXNARD STREET STREET 2: SUITE 830 CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 8186760404 MAIL ADDRESS: STREET 1: 1200 17TH STREET STREET 2: SUITE 1000 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: VERSAILLES CAPITAL CORP /CO DATE OF NAME CHANGE: 19970714 FORMER COMPANY: FORMER CONFORMED NAME: MAN O WAR INC /CO/ DATE OF NAME CHANGE: 19970714 8-K 1 FORM 8-K DATED FEBRUARY 7, 2000 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2000 ----------------------- AMERIMMUNE PHARMACEUTICALS, INC. - -------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Colorado 0-22865 84-1044910 - -------------------------------------------------------------------------- (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.) 21550 Oxnard Street, Suite 830, Woodland Hills, California 91367 - -------------------------------------------------------------------------- (Address of Principal Executive Offices) Zip Code Registrant's telephone number, including area code: (818) 676-0404 --------------------- N/A - -------------------------------------------------------------------------- (Former Name or Former Address, if Changed since Last Report) Item 5. Other Events. - ---------------------- Daniel L. Azarnoff, M.D. and Roy S. Azarnoff resigned as directors from the Board of Directors of Amerimmune Pharmaceuticals, Inc., effective February 7, 2000. Roy S. Azarnoff resigned as secretary/treasurer of Amerimmune Pharmaceuticals, Inc., effective February 7, 2000. The vacancies created by the resignations shall be filled by the Director's at a later date. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. AMERIMMUNE PHARMACEUTICALS, INC. (Registrant) By: /s/ DEBORAH GARRETT KALOF ---------------------------- Deborah Garrett Kalof Chief Financial Officer Date: April 10, 2000 2 -----END PRIVACY-ENHANCED MESSAGE-----